Main Menu

Coronavirus (COVID-19)

Coronavirus updates

Last updated 11 June

This page will collect together the latest information about The Institute of Cancer Research's response to coronavirus (COVID-19) as relates to our staff and students, as well as to visitors, fundraisers, and other external stakeholders.

We are following the latest advice for the UK from the Department of Health and Social Care and Public Health England and ICR staff and students should use the official Government response page for the latest information. 

Impact on research

ICR researchers are returning to their labs and restarting the many experiments that they have had to pause during lockdown. Staff and students will be coming onto site using staggered working patterns, to accommodate as many researchers as possible safely.

Although the coronavirus pandemic has been enormously disruptive to our work, we have still managed to continue our research in many areas, including our world-leading computational research in cancer genetics, evolution, drug discovery and clinical trials data.

Our Clinical Trials and Statistics Unit has also issued a statement regarding the effect of COVID-19 on our clinical trials.


Dates provided for interviews (for career vacancies as well as for PhD studentships) are liable to change and interviews should now take place using video conferencing solutions where possible. We will notify applicants of any changes as soon as we can.

Travel advice

The Mayor of London has advised the public to wear face coverings for the full duration of journeys on the public transport network from Monday 15 June and to use existing or new walking and cycling routes. Please check the Transport for London website before travelling in London.

Disruption to sporting events

Some of our fundraising events have been disrupted. If you were due to take part in the following events on behalf of the ICR, please contact [email protected]. We also suggest that people visit the official websites for any events for the latest updates.

Latest COVID-19 news